Literature DB >> 8364742

Delayed matching-to-sample, object retrieval, and discrimination reversal deficits in chronic low dose MPTP-treated monkeys.

J S Schneider1, D P Roeltgen.   

Abstract

Cognitive deficits following chronic exposure to low doses of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) were studied in monkeys asymptomatic for a gross parkinsonian motor disorder. Monkeys developed deficits in performance of delayed matching-to-sample, visual pattern discrimination reversal, and object retrieval tasks, all tasks that rely upon the integrity of the frontal-striatal axis. Performance on a visual pattern discrimination task, that relies primarily on inferotemporal cortex function, remained intact. These results extend previous findings of frontal-like cognitive deficits in MPTP-treated monkeys and further support the use of this model for studying the pathophysiology of the cognitive deficits associated with parkinsonism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8364742     DOI: 10.1016/0006-8993(93)90049-s

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  22 in total

1.  Clonidine improves attentional and memory components of delayed response performance in a model of early Parkinsonism.

Authors:  J S Schneider; J P Tinker; E Decamp
Journal:  Behav Brain Res       Date:  2010-03-27       Impact factor: 3.332

2.  Targeting Dopamine in Acute Traumatic Brain Injury.

Authors:  James W Bales; Anthony E Kline; Amy K Wagner; C Edward Dixon
Journal:  Open Drug Discov J       Date:  2010

3.  Behavioral toxicology of cognition: extrapolation from experimental animal models to humans: behavioral toxicology symposium overview.

Authors:  Merle G Paule; Leonard Green; Joel Myerson; Maria Alvarado; Jocelyne Bachevalier; Jay S Schneider; Susan L Schantz
Journal:  Neurotoxicol Teratol       Date:  2012-01-28       Impact factor: 3.763

Review 4.  The neurobiological basis of cognitive impairment in Parkinson's disease.

Authors:  Glenda M Halliday; James B Leverenz; Jay S Schneider; Charles H Adler
Journal:  Mov Disord       Date:  2014-04-15       Impact factor: 10.338

5.  MPTP-induced executive dysfunction is associated with altered prefrontal serotonergic function.

Authors:  Panchanan Maiti; Laura C Gregg; Michael P McDonald
Journal:  Behav Brain Res       Date:  2015-09-21       Impact factor: 3.332

6.  Modeling Parkinson's disease in primates: The MPTP model.

Authors:  Gregory Porras; Qin Li; Erwan Bezard
Journal:  Cold Spring Harb Perspect Med       Date:  2012-03       Impact factor: 6.915

Review 7.  Modeling Parkinson's disease in monkeys for translational studies, a critical analysis.

Authors:  Lisa F Potts; Hao Wu; Arun Singh; Irene Marcilla; Maria R Luquin; Stella M Papa
Journal:  Exp Neurol       Date:  2013-09-23       Impact factor: 5.330

8.  Attention, executive functioning and memory in normal aged rhesus monkeys.

Authors:  Alyson Zeamer; Emmanuel Decamp; Kathryn Clark; J S Schneider
Journal:  Behav Brain Res       Date:  2010-12-17       Impact factor: 3.332

9.  European clinical guidelines for hyperkinetic disorder -- first upgrade.

Authors:  Eric Taylor; Manfred Döpfner; Joseph Sergeant; Philip Asherson; Tobias Banaschewski; Jan Buitelaar; David Coghill; Marina Danckaerts; Aribert Rothenberger; Edmund Sonuga-Barke; Hans-Christoph Steinhausen; Alessandro Zuddas
Journal:  Eur Child Adolesc Psychiatry       Date:  2004       Impact factor: 4.785

Review 10.  Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.

Authors:  Patricia S Goldman-Rakic; Stacy A Castner; Torgny H Svensson; Larry J Siever; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.